Comprehensive EKG Course (20.0 CME Credits)
Comprehensive EKG Course (20.0 CME Credits)
  • Purchase includes:
    • 12-month online access to all course material
    • 20.0 CME credits and certificate upon completing course requirements
  • Course instructor: Anthony Kashou, MD (The EKG Guy)
  • Course overview: The Comprehensive EKG Course is an accredited course designed for those with little to no knowledge of EKGs as well as those interested in a refresher in EKG interpretation from beginner to advanced topics. It is comprised of 133 lessons with corresponding videos and abundant practice material to master topics along the way. Course objectives are described below.
  • Target audience: This activity is appropriate for all healthcare providers interested in learning more about ECG interpretation, especially ECG technicians, physicians, and allied health staff among others.
  • Credit and certificate requirements:
    • Complete pre-course assessment
    • Complete all 133 lesson videos and corresponding practice material
    • Successfully pass post-course assessment
    • Complete course evaluation
  • Important disclaimer: Some content in this course is included in other CME courses (e.g., High-Yield EKG course). Therefore, if you do enroll and receive credit from this course, you will not be eligible to claim it for any other course. If duplicate credit is accidentally claimed, it will not be valid should any auditing occur. Please do not hesitate to contact us with any questions or concerns prior to purchasing.
jaiAccreditation Statement: In support of improving patient care, this activity is planned and implemented by Mayo Clinic College of Medicine and Science and The EKG Guy.  Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement: 
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 20.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Objectives
  1. Describe basic cardiac anatomy and circulation.
  2. Describe the electrical conduction system of the heart.
  3. Identify the locations of various leads on the standard 12-lead ECG.
  4. Identify and describe various aspects of the cardiac cycle and their normal appearance on the EKG.
  5. Determine the regularity and rate of a rhythm.
  6. Describe and determine ventricular (QRS) axis in the frontal plane.
  7. Describe and determine transition zone and R wave progression in the precordial leads.
  8. Explain the mechanism of various atrial rhythms.
  9. Describe the ECG features associated with various atrial rhythms.
  10. Identify various atrial rhythms on a 12-lead ECG.
  11. Explain the mechanism of various AV junctional rhythms.
  12. Describe the ECG features associated with various AV junctional rhythms.
  13. Identify various AV junctional rhythms on a 12-lead ECG.
  14. Explain the mechanism of various ventricular rhythms.
  15. Describe the ECG features associated with various ventricular rhythms.
  16. Identify various ventricular rhythms on a 12-lead ECG.
  17. Describe the clinical significance of various atrial, AV junctional, and ventricular rhythms.
  18. Describe the difference between asystole and pulseless electrical activity.
  19. Identify the basic ECG features associated with single-chamber atrial and ventricular pacemakers as well as with dual-chamber pacemakers.
  20. Describe the ECG features associated with left atrial, right atrial, and biatrial enlargement.
  21. Identify left atrial, right atrial, and biatrial enlargement on a standard 12-lead ECG.
  22. Describe clinical conditions associated with left atrial, right atrial, and biatrial enlargement.
  23. Describe the ECG features associated with left ventricular, right ventricular, and biventricular hypertrophy.
  24. Identify left ventricular, right ventricular, and biventricular hypertrophy on a standard 12-lead ECG.
  25. Describe clinical conditions associated with left ventricular, right ventricular, and biventricular hypertrophy.
  26. Describe the ECG features associated with various forms of atrioventricular (AV) blocks and intraventricular conduction defects.
  27. Identify various forms of AV blocks and intraventricular conduction defects on a standard 12-lead ECG.
  28. Describe clinical conditions associated with various forms of AV blocks and intraventricular conduction defects.
  29. Recall the normal cardiac anatomy and distribution of myocardial blood flow.
  30. Recall the definition and underlying pathophysiology of myocardial ischemia and infarction.
  31. Describe the difference between stable angina, unstable angina, non-ST elevation myocardial infarction (NSTEMI), and ST-elevation myocardial infarction (STEMI).
  32. Describe ST-segment and T wave changes suggestive of myocardial ischemia.
  33. Describe the ECG findings necessary to fulfill STEMI criteria.
  34. Identify myocardial ischemia and injury on a standard 12-lead ECG.
  35. Describe and identify the findings of non-STEMI equivalent patterns (eg, Wellens' syndrome, de Winter's sign) on a standard 12-lead ECG.
  36. Localize myocardial injury to various regions of the heart.
  37. Describe the what is meant by coronary artery dominance.
  38. Describe the left ventricular anatomy and vascular supply.
  39. Identify the culprit coronary artery in myocardial ischemia based on a standard 12-lead ECG.
  40. Define Prinzmetal's angina and its associated ECG findings.
  41. Recall the coronary arteries that supply various components of the heart's electrical conduction system.
  42. Describe and identify the findings associated with myocardial ischemia in the setting of left bundle branch block or a ventricular-paced rhythm.
  43. Describe the conduction defects associated with myocardial infarction involving various regions.
  44. Describe and identify the ECG features associated with hypothermia, intracranial hemorrhage, early repolarization, acute pericarditis, and pericardial effusion.
  45. Describe and identify the key ECG features associated with various inherited arrhythmia disorders (eg, Brugada syndrome, long and short QT syndrome, arrhythmogenic right ventricular dysplasia).
  46. Identify key ECG features associated with various electrolyte disturbances.
  47. Describe the mechanism and physiologic effects of digoxin.
  48. Define the ECG features associated with digoxin effect and toxicity.
  49. Explain the purpose of Einthoven's triangle.
  50. Identify bipolar and augmented unipolar leads.
  51. Describe limb electrode placement and the limb leads that generate from the electrodes.
  52. Explain what occurs to Einthoven's triangle in various limb lead reversals.
  53. Identify the presence and type of lead reversal present based on a standard 12-lead ECG.
  54. Identify the culprit electrode associated with artifact.
  55. Define the expected ECG features associated with various forms of motion and muscle artifacts.
  56. Identify motion and muscle artifact on a standard 12-lead ECG.
Additonal Course Information
  • Disclosure summary: As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.
  • Relevant financial relationship(s) with industry: None.
  • No relevant financial relationship(s) with industry: Anthony Kashou, M.D.
  • References to off-label and/or investigational usage(s) of pharmaceuticals or instruments in their presentation: None.
  • Disclaimer: Participation in this educational activity does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course. You should be aware that substantive developments in the medical field covered by this recording may have occurred since the date of original release.
  • Prerequisites for participation: There are no prerequisites needed prior to participating in this education activity.
  • Method of participation: Participation in this activity consists of reviewing the educational material, completing the learner assessment, and course evaluation.
  • Release date: 01/01/2021
  • Expiration date: 12/31/2024
  • Acknowledgement of Commercial Support: No commercial support was received in the production of this activity.
  • Bibliographic Resources: Bibliographic resources are provided within the activity.
Progress

Instructors
Anthony Kashou